13F-HR filed by Sio Capital Management, LLC
Sio Capital Management, LLC filed this 13F-HR for the quarter ended 2026-09-30, accepted by EDGAR 2026-11-16 18:00:13 UTC, with 55 holding rows worth $528,521,218.
- Accession
- 0001214659-26-014302
- Filer
- CIK 1482416
- Filed
- 2026-11-16
- Accepted by EDGAR
- Ingested
- Source
- EDGAR live feed
13F report for Q3 2026
A holdings report, 55 entries on the cover page, a total value of $528,521,218 stated on the cover page (in dollars after the unit check, H1), rows summing to $528,521,218 with VALUE read as dollars as filed, 13F file number 028-13691. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| ANTERIS TECHNOLOGIES GLOBAL | 03675P102 | COMMON STOCK | 5,179,464 | $40,244,435 | dollars as filed | |
| GLOBUS MED INC CL A | 379577208 | Stock | 476,109 | $35,660,564 | dollars as filed | |
| GSK PLC SPONSORED ADR | 37733W204 | ADR | 671,121 | $32,327,899 | dollars as filed | |
| ICON PUB LTD CO SHS | G4705A100 | Stock | 140,999 | $23,968,420 | dollars as filed | |
| SENSEONICS HOLDINGS INC | 81727U303 | COMMON STOCK | 2,290,860 | $23,298,046 | dollars as filed | |
| Merck & Co.,Inc. | 58933Y105 | COM | 150,000 | $21,796,500 | dollars as filed | put |
| Merck & Co.,Inc. | 58933Y105 | COM | 145,485 | $21,140,425 | dollars as filed | |
| IDEAYA BIOSCIENCES INC COM | 45166A102 | Stock | 500,117 | $19,214,495 | dollars as filed | |
| Pfizer Inc. | 717081103 | COM | 600,000 | $17,112,000 | dollars as filed | put |
| SELLAS LIFE SCIENCES GROUP I | 81642T209 | COM NEW | 1,230,700 | $15,149,917 | dollars as filed | put |
| SANOFI SA SPONSORED ADR | 80105N105 | ADR | 356,182 | $14,685,384 | dollars as filed | |
| ALLOGENE THERAPEUTICS INC | 019770106 | COM | 9,104,151 | $14,566,642 | dollars as filed | |
| MAXIMUS INC | 577933104 | COM | 268,280 | $14,269,813 | dollars as filed | |
| RELMADA THERAPEUTICS INC | 75955J402 | COMMON STOCK | 3,629,844 | $13,684,512 | dollars as filed | |
| VIATRIS INC COM | 92556V106 | Stock | 755,490 | $13,387,283 | dollars as filed | |
| AVEANNA HEALTHCARE HLDGS INC | 05356F105 | COM | 1,012,102 | $12,560,186 | dollars as filed | |
| REPLIMUNE GROUP INC | 76029N106 | COMMON STOCK | 865,331 | $11,456,982 | dollars as filed | |
| TANGO THERAPEUTICS INC | 87583X109 | COM | 428,860 | $10,700,057 | dollars as filed | |
| ANI PHARMACEUTICALS INC | 00182C103 | COM | 146,268 | $10,626,370 | dollars as filed | |
| BIOMARIN PHARMACEUTICAL INC | 09061G101 | COM | 174,311 | $10,458,660 | dollars as filed | |
| CELCUITY INC | 15102K100 | COM | 126,339 | $10,046,477 | dollars as filed | |
| ASTRAZENECA PLC ORD | G0593M107 | ADR | 61,848 | $9,986,597 | dollars as filed | |
| RAPPORT THERAPEUTICS INC COM | 75383L102 | Stock | 291,231 | $9,785,362 | dollars as filed | |
| VIR BIOTECHNOLOGY INC | 92764N102 | COM | 873,375 | $9,764,333 | dollars as filed | |
| Cigna Corporation | 125523100 | COM | 33,935 | $9,224,551 | dollars as filed | |
| COOPER COS INC | 216648501 | COM | 158,053 | $8,934,736 | dollars as filed | |
| LIQUIDIA CORPORATION COM NEW | 53635D202 | Stock | 282,000 | $8,533,320 | dollars as filed | |
| CYBIN INC | 23256X407 | COM NEW | 561,289 | $6,898,242 | dollars as filed | |
| PROTARA THERAPEUTICS INC | 74365U107 | COM STK | 1,991,339 | $6,073,584 | dollars as filed | |
| PMV PHARMACEUTICALS INC | 69353Y103 | COM | 3,634,137 | $6,069,009 | dollars as filed | |
| AQUESTIVE THERAPEUTICS INC COM | 03843E104 | Stock | 1,278,056 | $5,917,399 | dollars as filed | |
| PTC THERAPEUTICS INC | 69366J200 | COM | 82,900 | $5,370,262 | dollars as filed | |
| CORBUS PHARMACEUTICALS | 21833P301 | COM NEW | 766,364 | $5,226,602 | dollars as filed | |
| RAINIER ACQUISITION CORP | G73591110 | UNIT | 500,000 | $5,100,000 | dollars as filed | |
| HAEMONETICS CORP MASS COM | 405024100 | Stock | 44,700 | $4,706,910 | dollars as filed | put |
| Q32 BIO INC | 746964105 | Common Stock | 529,155 | $4,376,112 | dollars as filed | |
| SERINA THERAPEUTICS INC | 81751A108 | COM SHS | 2,000,000 | $4,000,000 | dollars as filed | |
| BRIGHT MINDS BIOSCIENCES INC | 10919W405 | COMMON STOCK | 75,152 | $3,744,073 | dollars as filed | |
| SAVARA INC | 805111101 | COM | 657,104 | $3,390,657 | dollars as filed | |
| ONKURE THERAPEUTICS INC | 68277Q105 | COM CL A | 1,082,965 | $2,951,080 | dollars as filed | |
| AN2 THERAPEUTICS INC | 037326105 | COM | 548,103 | $2,915,908 | dollars as filed | |
| IMMUNOME INC | 45257U108 | COM | 132,097 | $2,841,406 | dollars as filed | |
| ZENAS BIOPHARMA INC COM | 98937L105 | Stock | 95,457 | $2,574,475 | dollars as filed | |
| OVID THERAPEUTICS INC | 690469101 | COMMON STOCK | 1,005,334 | $2,503,282 | dollars as filed | |
| ALIGOS THERAPEUTICS INC | 01626L204 | COM NEW | 327,237 | $1,842,344 | dollars as filed | |
| FULCRUM THERAPEUTICS INC | 359616109 | COMMON STOCK | 481,601 | $1,781,924 | dollars as filed | |
| ALIGNMENT HEALTHCARE INC COM | 01625V104 | Stock | 184,424 | $1,504,900 | dollars as filed | |
| XILIO THERAPEUTICS INC | 98422T209 | COM | 152,464 | $1,379,799 | dollars as filed | |
| EYEPOINT INC COM NEW | 30233G209 | Stock | 373,666 | $1,221,888 | dollars as filed | |
| QT IMAGING HLDGS INC | 746962307 | COM | 440,446 | $1,120,935 | dollars as filed | |
| IBIO INC | 451033708 | CMN | 904,268 | $1,067,036 | dollars as filed | |
| TELA BIO INC | 872381108 | COM | 636,300 | $731,745 | dollars as filed | |
| ENVERIC BIOSCIENCES INC | 29405E505 | COM SHS | 330,000 | $490,050 | dollars as filed | |
| NEUROONE MED TECHNOLOGIES CO | 64130M308 | COM | 82,767 | $85,250 | dollars as filed | |
| Modular Medical, Inc. | 60785L306 | COM | 26,190 | $52,380 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001214659-26-014302 | this filing | 2026-11-16 |